Barclays Cuts Charles River Labs, Sees Lack Of Demand Proof Over Long-Term
July 10, 2015 at 08:11 AM EDT
In a report published Friday, Barclays analyst Douglas D. Tsao downgraded the rating on Charles River Laboratories (NYSE: CRL) from ...